{"title":"氟-18氟脱氧葡萄糖正电子发射断层扫描检测肝细胞癌门静脉肿瘤血栓的作用","authors":"Y. Sreenija, D. Dutta","doi":"10.47363/jghr/2022(3)129","DOIUrl":null,"url":null,"abstract":"A 56 year old gentleman with no known comorbidities presented with pain abdomen for 1 month. Triphasic CECT abdomen showed features of cirrhosis with surface irregularities, fissural widening and volume redistribution changes in the liver. Segment VII of liver showed an arterial enhancing lesion measuring 4.2 x 3.5cm showing washout in delayed phase. In view of BCLC A stage with Child Pugh B7, ablation was planned. Before proceeding with ablation, in view of very high alpha-fetoprotein (AFP) level of 9836 ng/mL, he was advised for metastatic evaluation with 18F-FDG PET-CT. The PET scan showed abnormal heterogeneous increased FDG uptake in segment VII of liver (SUV Max 4.7) with arterial enhancement and washout suggestive of metabolically active hepatocellular carcinoma. Also seen was an abnormal linear increased FDG uptake in right branch of portal vein (SUV Max 4.8) which was suggestive of portal vein invasion. In view of portal vein tumor thrombus, ablation procedure was deferred for the patient. Role of PET scan in HCC with vascular invasion is not yet defined. Poor specificity of FDG PET is the major hindrance in establishing PET scan as diagnostic tool for vascular invasion. In small segment invasion when CECT is not able to differentiate between tumour versus bland thrombus PET scan may be significant tool to differentiate between bland thrombus and tumour thrombus. Vascular invasion confirmation have treatment related and prognostic significance. There is a need for a prospective study evaluating the prognostic significance of PET scan based diagnosis of vascular invasion.","PeriodicalId":363979,"journal":{"name":"Journal of Gastroenterology & Hepatology Reports","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Detection of Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma\",\"authors\":\"Y. Sreenija, D. Dutta\",\"doi\":\"10.47363/jghr/2022(3)129\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 56 year old gentleman with no known comorbidities presented with pain abdomen for 1 month. Triphasic CECT abdomen showed features of cirrhosis with surface irregularities, fissural widening and volume redistribution changes in the liver. Segment VII of liver showed an arterial enhancing lesion measuring 4.2 x 3.5cm showing washout in delayed phase. In view of BCLC A stage with Child Pugh B7, ablation was planned. Before proceeding with ablation, in view of very high alpha-fetoprotein (AFP) level of 9836 ng/mL, he was advised for metastatic evaluation with 18F-FDG PET-CT. The PET scan showed abnormal heterogeneous increased FDG uptake in segment VII of liver (SUV Max 4.7) with arterial enhancement and washout suggestive of metabolically active hepatocellular carcinoma. Also seen was an abnormal linear increased FDG uptake in right branch of portal vein (SUV Max 4.8) which was suggestive of portal vein invasion. In view of portal vein tumor thrombus, ablation procedure was deferred for the patient. Role of PET scan in HCC with vascular invasion is not yet defined. Poor specificity of FDG PET is the major hindrance in establishing PET scan as diagnostic tool for vascular invasion. In small segment invasion when CECT is not able to differentiate between tumour versus bland thrombus PET scan may be significant tool to differentiate between bland thrombus and tumour thrombus. Vascular invasion confirmation have treatment related and prognostic significance. There is a need for a prospective study evaluating the prognostic significance of PET scan based diagnosis of vascular invasion.\",\"PeriodicalId\":363979,\"journal\":{\"name\":\"Journal of Gastroenterology & Hepatology Reports\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastroenterology & Hepatology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jghr/2022(3)129\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology & Hepatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jghr/2022(3)129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
56岁男性,无已知合并症,腹痛1个月。腹部三相CECT表现为肝硬化,肝表面不规则,肝裂增宽,体积再分布改变。肝脏第七节段显示4.2 x 3.5cm的动脉增强病变,呈延迟期冲洗。鉴于BCLC A期伴Child Pugh B7,计划行消融治疗。在继续消融之前,考虑到非常高的甲胎蛋白(AFP)水平9836 ng/mL,建议用18F-FDG PET-CT评估转移性。PET扫描显示肝脏第七段FDG摄取异常异质增加(SUV Max 4.7),动脉增强和冲洗提示代谢活跃的肝细胞癌。门静脉右支FDG摄取异常线性增加(SUV Max 4.8),提示门静脉侵犯。考虑到门静脉肿瘤血栓,患者延期行消融手术。PET扫描在肝细胞癌伴血管侵犯中的作用尚未明确。FDG PET特异性差是阻碍PET扫描作为血管侵犯诊断工具的主要障碍。在小段侵犯时,当CECT不能区分肿瘤和无症状血栓时,PET扫描可能是区分无症状血栓和肿瘤血栓的重要工具。血管侵犯的确认对治疗和预后有重要意义。有必要进行一项前瞻性研究,评估基于PET扫描诊断血管侵犯的预后意义。
Role of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Detection of Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma
A 56 year old gentleman with no known comorbidities presented with pain abdomen for 1 month. Triphasic CECT abdomen showed features of cirrhosis with surface irregularities, fissural widening and volume redistribution changes in the liver. Segment VII of liver showed an arterial enhancing lesion measuring 4.2 x 3.5cm showing washout in delayed phase. In view of BCLC A stage with Child Pugh B7, ablation was planned. Before proceeding with ablation, in view of very high alpha-fetoprotein (AFP) level of 9836 ng/mL, he was advised for metastatic evaluation with 18F-FDG PET-CT. The PET scan showed abnormal heterogeneous increased FDG uptake in segment VII of liver (SUV Max 4.7) with arterial enhancement and washout suggestive of metabolically active hepatocellular carcinoma. Also seen was an abnormal linear increased FDG uptake in right branch of portal vein (SUV Max 4.8) which was suggestive of portal vein invasion. In view of portal vein tumor thrombus, ablation procedure was deferred for the patient. Role of PET scan in HCC with vascular invasion is not yet defined. Poor specificity of FDG PET is the major hindrance in establishing PET scan as diagnostic tool for vascular invasion. In small segment invasion when CECT is not able to differentiate between tumour versus bland thrombus PET scan may be significant tool to differentiate between bland thrombus and tumour thrombus. Vascular invasion confirmation have treatment related and prognostic significance. There is a need for a prospective study evaluating the prognostic significance of PET scan based diagnosis of vascular invasion.